CoreMap Completes $10.5 Million Series A Financing
CoreMap notes the funds will be used to accelerate the Company’s ongoing product development and their planned regulatory submission of the Company’s first products.
September 16, 2020
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
CoreMap notes the funds will be used to accelerate the Company’s ongoing product development and their planned regulatory submission of the Company’s first products.
Spine Align reports the financing is led by the Rockies Venture Club, with additional support by members of the Berkeley Angel Network, NO/LA Angel Network, Pasadena Angels, Bellingham Angels, the Abell Foundation, and VentureWell.
Adona Medical notes the financing was led by Cormorant Asset Management, with participation from Excelestar Ventures, AMED Ventures, and select angel investors, and included previous debt investments that converted to preferred shares.